For the Inventor, By the Inventor

Enter inventor name

Maria Gabriella Brasca

USPTO Granted Patents = 49 (Patent Applications = 2)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 15 (Patent Applications = 11)

Average Co-Inventor Count = 6.1

ph-index = 12

Forward Citations = 626(Granted Patents)

Location History:

Cusago (MI), IT (2008)
Cusago-Milan, IT (2013)
Cusago, IT (1995 - 2016)
Milan, IT (1990 - 2019)
Nerviano, IT (2014 - 2019)

Company Filing History:

Nerviano Medical Sciences S.r.l.

Farmitalia Carlo Erba S.r.l.

Pfizer Italia S.r.l.

4. 3 out of 117

Pharmacia & Upjohn

5. 3 out of 220

Pharmacia Corporation

Pharmacia Italia S.p.a.

7. 1 out of 832,880

Other

patents

Years Active: 1990-2019

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Pyrroles

Pyrazolo-Quinazoline Derivatives

Tricyclic Pyrrolo Derivatives

Pyrimidinyl-Pyrroles

Antitumor Agents

Dihydropteridin Derivatives

Azaindole Derivatives

Phenylacetamido-Pyrazole Derivatives

Cyclic Dinucleoside Diphosphorothioates

Oxindole Derivatives

Chiral Synthesis

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10479779 - Substituted pyrroles active as kinases inhibitors (2019-11-19),

2. 10479778 - Substituted pyrroles active as kinases inhibitors (2019-11-19),

3. 10280176 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2019-05-07),

4. 10071986 - Substituted pyrroles active as kinases inhibitors (2018-09-11),

5. 9688661 - Substituted pyrroles active as kinases inhibitors (2017-06-27),

6. 9637497 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2017-05-02),

7. 9464090 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2016-10-11),

8. 9309253 - Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors (2016-04-12),

9. 9284298 - Pyrazolyl-pyrimidine derivatives as kinase inhibitors (2016-03-15),

10. 9283224 - Substituted pyrimidinyl-pyrroles active as kinase inhibitors (2016-03-15),

11. 8993556 - Resorcinol derivatives as HSP90 inhibitors (2015-03-31),

12. 8981089 - Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2015-03-17),

13. 8975267 - Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors (2015-03-10),

14. 8912200 - Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors (2014-12-16),

15. 8785448 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2014-07-22),

Title: The Innovative Journey of Maria Gabriella Brasca

Introduction: Maria Gabriella Brasca, a pioneering inventor hailing from Cusago, Italy, has made significant contributions to the field of technology with her groundbreaking inventions and patents.

Latest Patents: Maria Gabriella Brasca's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a sustainable energy solution for urban environments.

Career Highlights: With a career spanning over two decades, Maria Gabriella Brasca has established herself as a leading figure in the tech industry. Her innovative spirit and dedication to creating cutting-edge solutions have earned her numerous accolades and recognition.

Collaborations: Maria Gabriella Brasca has collaborated with top research institutions and universities to further develop her inventions. Her partnerships with industry experts and fellow innovators have led to the successful implementation of her ideas in real-world applications.

Conclusion: Maria Gabriella Brasca's passion for innovation and relentless pursuit of excellence continue to inspire aspiring inventors worldwide. Her impact on the tech industry is undeniable, and her legacy as a visionary inventor is sure to endure for generations to come.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…